Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott

finance.yahoo.com · 2026-09-13

Both Medtronic and Abbott have raised their dividends for nearly half a century, but retirement investors with limited capital can only choose one. The case for each is stronger than most comparisons admit, and the tiebreaker comes down to a single question about your timeline.

TickrTrends take: Abbott is positioned as one of two major medical device companies being evaluated for dividend appeal, a comparison that underscores investor interest in the Healthcare sector's established players. TickrTrends currently derives an Undervalued verdict for ABT, suggesting the market may not be fully pricing in the company's dividend and operational profile relative to peers. For valuation-focused readers, the key consideration is whether Abbott's valuation discount versus comparable companies like Medtronic reflects genuine opportunity or market-based concerns about relative performance.

Read the full story at finance.yahoo.com →